TickerFacts.

Company research / BDX

Becton Dickinson & Co (BDX)

Build a valuation ↗↓ Download CSV

SEC name BECTON DICKINSON & CO · CIK 0000010795 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated NJ
  • Fiscal year ends Sep 30

For the year ended 2025-09-30, Becton Dickinson & Co reported revenue of $21.84B. Revenue grew 8.2% from the prior annual period.

Key ratios (year ended 2025-09-30)

45.4%
Gross margin (computed)
11.8%
Operating margin
7.7%
Net margin
6.6%
Return on year-end equity
8.2%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-29

Headquarters locality: Becton, Dickinson and Company headquarters / San Jose · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-30
Revenuen/a$21.84B$20.18B$19.37B$18.87B$19.13B$16.07B$17.29B$15.98B$12.09B$12.48B
Cost of Revenuen/a$11.91B$11.05B$11.20B$10.39B$10.50B$9.28B$9.00B$8.71B$6.13B$6.49B
Gross Profit (computed)n/a$9.93B$9.12B$8.17B$8.48B$8.63B$6.80B$8.29B$7.27B$5.96B$5.99B
R&D Expensen/a$1.26B$1.19B$1.24B$1.26B$1.28B$1.04B$1.06B$1.00B$770.00M$828.00M
Operating Incomen/a$2.58B$2.40B$2.11B$2.28B$2.25B$912.00M$1.76B$1.51B$1.52B$1.43B
Depreciation & Amortizationn/a$2.46B$2.29B$2.29B$2.23B$2.23B$2.12B$2.25B$1.98B$1.09B$1.11B
EBITDAn/a$5.04B$4.68B$4.40B$4.51B$4.48B$3.03B$4.01B$3.49B$2.61B$2.54B
Net Income$942.00M$1.68B$1.71B$1.48B$1.78B$2.09B$874.00M$1.23B$311.00M$1.10B$976.00M
EPS (Diluted)n/a$5.82$5.86$4.94$5.88$6.85$2.71$3.94$0.60$4.60$4.49
Total Assets$50.73B$55.33B$57.29B$52.78B$52.93B$53.87B$54.01B$51.77B$53.90B$37.73B$25.59B
Shareholders' Equity$24.42B$25.39B$25.89B$25.80B$25.28B$23.68B$23.77B$21.08B$20.99B$12.95B$7.63B
Cash & Equivalents$708.00M$641.00M$1.72B$1.42B$1.01B$2.28B$2.83B$536.00M$1.14B$14.18B$1.54B
Operating Cash Flown/a$3.43B$3.84B$2.99B$2.47B$4.13B$2.94Bn/an/an/an/a
Capital Expendituresn/a$760.00M$725.00M$874.00M$973.00M$1.19B$769.00M$957.00M$895.00M$727.00M$693.00M
Free Cash Flown/a$2.67B$3.12B$2.12B$1.50B$2.93B$2.17Bn/an/an/an/a
Share Repurchases$2.50B$1.00B$500.00M$0$500.00M$1.75B$0$0$0$220.00M$0
Dividends Paidn/a$1.20B$1.10B$1.11B$1.08B$1.05B$1.03B$984.00M$927.00M$677.00M$562.00M
Dividends Per Sharen/a$4.16$3.80$3.64$3.48$3.32$3.16$3.08$3.00$2.92$2.64
Weighted Average Diluted Sharesn/a288.51M291.01M288.39M287.36M292.09M282.40M274.77M264.62M223.59M217.54M
EPS (Basic)n/a$5.83$5.88$4.97$5.93$6.92$2.75$4.01$0.62$4.70$4.59

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView